Subsequently, five genes (C6, UGT2B7, SLC22A1, F11, and CYP2C8) were identified as potential novel diagnostic biomarkers and four genes (CYS2, F11, ANXA10, and SLC22A1) were identified as potential novel prognostic biomarkers in HCC. This evidence concerns the gene ANXA10 and hepatocellular carcinoma.